TY - JOUR
T1 - Direct sequencing analysis of transmembrane region of human neu gene by polymerase chain reaction
AU - Saya, Hideyuki
AU - Ara, Seiji
AU - Lee, Polly S.Y.
AU - Ro, Jungsil
AU - Hung, Mien‐Chie ‐C
PY - 1990
Y1 - 1990
N2 - The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu‐encoded p185 protein. The human homologue of the rat neu gene, termed c‐erbB‐2 or HER‐2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmebrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrance region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.
AB - The neu gene in rat neuro/glioblastoma was found to be activated by a single point mutation in the DNA sequence encoding the transmembrane region of the neu‐encoded p185 protein. The human homologue of the rat neu gene, termed c‐erbB‐2 or HER‐2, can also be activated in vitro by a similar mutation in the corresponding region. Although the human neu gene was shown to be amplified/overexpressed in a large portion of human breast and ovarian cancer, no reports indicate that the human neu gene is activated by a point mutation in human tumor. To study the possible point mutation of neu gene in human tumors, we characterized the genomic structure in the transmebrane region of human neu gene, which in turn allowed us to determine DNA sequence in this region directly following DNA amplification by polymerase chain reaction. We analyzed 7 tumor cell lines (2 breast cancer, 1 neuroblastoma, 1 rhabdomyosarcoma, and 3 glioma) and 11 tumor tissue samples (8 breast and 3 ovarian cancers). No mutation was found in the transmembrane region of human neu gene. Our results suggest that unlike the rat neuro/glioblastoma, the single point mutation in the transmembrance region of the human neu gene is a rare event in human tumors. In this study, we developed a technique for direct DNA sequencing of the transmembrane region of the human neu gene. This technique makes it possible to screen a large number of tumor samples.
UR - http://www.scopus.com/inward/record.url?scp=0025167538&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025167538&partnerID=8YFLogxK
U2 - 10.1002/mc.2940030406
DO - 10.1002/mc.2940030406
M3 - Article
C2 - 2206283
AN - SCOPUS:0025167538
SN - 0899-1987
VL - 3
SP - 198
EP - 201
JO - Molecular Carcinogenesis
JF - Molecular Carcinogenesis
IS - 4
ER -